L L L Yeo1, P Paliwal2, H L Teoh2, R C Seet3, B P Chan2, E Ting4, N Venketasubramanian2, W K Leow5, B Wakerley2, Y Kusama2, R Rathakrishnan2, V K Sharma3. 1. From the Division of Neurology, Department of Medicine (L.L.L.Y., P.P., H.L.T., R.C.S., B.P.C., N.V., B.W., Y.K., R.R., V.K.S.) leonard_ll_yeo@nuhs.edu.sg. 2. From the Division of Neurology, Department of Medicine (L.L.L.Y., P.P., H.L.T., R.C.S., B.P.C., N.V., B.W., Y.K., R.R., V.K.S.). 3. From the Division of Neurology, Department of Medicine (L.L.L.Y., P.P., H.L.T., R.C.S., B.P.C., N.V., B.W., Y.K., R.R., V.K.S.) Yong Loo Lin School of Medicine (R.C.S., V.K.S.), National University of Singapore, Singapore. 4. Department of Diagnostic Imaging (E.T.), National University Health System, Singapore. 5. Department of Computer Science (W.K.L.).
Abstract
BACKGROUND AND PURPOSE: Intracranial collaterals influence the prognosis of patients treated with intravenous tissue plasminogen activator in acute anterior circulation ischemic stroke. We compared the methods of scoring collaterals on pre-tPA brain CT angiography for predicting functional outcomes in acute anterior circulation ischemic stroke. MATERIALS AND METHODS: Two hundred consecutive patients with acute anterior circulation ischemic stroke treated with IV-tPA during 2010-2012 were included. Two independent neuroradiologists evaluated intracranial collaterals by using the Miteff system, Maas system, the modified Tan scale, and the Alberta Stroke Program Early CT Score 20-point methodology. Good and extremely poor outcomes at 3 months were defined by modified Rankin Scale scores of 0-1 and 5-6 points, respectively. RESULTS: Factors associated with good outcome on univariable analysis were younger age, female sex, hypertension, diabetes mellitus, atrial fibrillation, small infarct core (ASPECTS ≥8), vessel recanalization, lower pre-tPA NIHSS scores, and good collaterals according to Tan methodology, ASPECTS methodology, and Miteff methodology. On multivariable logistic regression, only lower NIHSS scores (OR, 1.186 per point; 95% CI, 1.079-1.302; P = .001), recanalization (OR, 5.599; 95% CI, 1.560-20.010; P = .008), and good collaterals by the Miteff method (OR, 3.341; 95% CI, 1.203-5.099; P = .014) were independent predictors of good outcome. Poor collaterals by the Miteff system (OR, 2.592; 95% CI, 1.113-6.038; P = .027), Maas system (OR, 2.580; 95% CI, 1.075-6.187; P = .034), and ASPECTS method ≤5 points (OR, 2.685; 95% CI, 1.156-6.237; P = .022) were independent predictors of extremely poor outcomes. CONCLUSIONS: Only the Miteff scoring system for intracranial collaterals is reliable for predicting favorable outcome in thrombolyzed acute anterior circulation ischemic stroke. However, poor outcomes can be predicted by most of the existing methods of scoring intracranial collaterals.
BACKGROUND AND PURPOSE: Intracranial collaterals influence the prognosis of patients treated with intravenous tissue plasminogen activator in acute anterior circulation ischemic stroke. We compared the methods of scoring collaterals on pre-tPA brain CT angiography for predicting functional outcomes in acute anterior circulation ischemic stroke. MATERIALS AND METHODS: Two hundred consecutive patients with acute anterior circulation ischemic stroke treated with IV-tPA during 2010-2012 were included. Two independent neuroradiologists evaluated intracranial collaterals by using the Miteff system, Maas system, the modified Tan scale, and the Alberta Stroke Program Early CT Score 20-point methodology. Good and extremely poor outcomes at 3 months were defined by modified Rankin Scale scores of 0-1 and 5-6 points, respectively. RESULTS: Factors associated with good outcome on univariable analysis were younger age, female sex, hypertension, diabetes mellitus, atrial fibrillation, small infarct core (ASPECTS ≥8), vessel recanalization, lower pre-tPA NIHSS scores, and good collaterals according to Tan methodology, ASPECTS methodology, and Miteff methodology. On multivariable logistic regression, only lower NIHSS scores (OR, 1.186 per point; 95% CI, 1.079-1.302; P = .001), recanalization (OR, 5.599; 95% CI, 1.560-20.010; P = .008), and good collaterals by the Miteff method (OR, 3.341; 95% CI, 1.203-5.099; P = .014) were independent predictors of good outcome. Poor collaterals by the Miteff system (OR, 2.592; 95% CI, 1.113-6.038; P = .027), Maas system (OR, 2.580; 95% CI, 1.075-6.187; P = .034), and ASPECTS method ≤5 points (OR, 2.685; 95% CI, 1.156-6.237; P = .022) were independent predictors of extremely poor outcomes. CONCLUSIONS: Only the Miteff scoring system for intracranial collaterals is reliable for predicting favorable outcome in thrombolyzed acute anterior circulation ischemic stroke. However, poor outcomes can be predicted by most of the existing methods of scoring intracranial collaterals.
Authors: Shervin Kamalian; Andre Kemmling; Roderick C Borgie; Livia T Morais; Seyedmehdi Payabvash; Ana M Franceschi; Shahmir Kamalian; Albert J Yoo; Karen L Furie; Michael H Lev Journal: Stroke Date: 2013-08-29 Impact factor: 7.914
Authors: T G Jovin; R Gupta; M B Horowitz; S Z Grahovac; C A Jungreis; L Wechsler; J M Gebel; H Yonas Journal: AJNR Am J Neuroradiol Date: 2007-01 Impact factor: 3.825
Authors: Limin Zhao; Kristian Barlinn; Asim K Bag; Maruthi Kesani; Luis F Cava; Clotilde Balucani; Anne W Alexandrov; Joseph A Horton; Damon E Patterson; Mark R Harrigan; Karen C Albright; Andrei V Alexandrov Journal: Int J Stroke Date: 2011-12 Impact factor: 5.266
Authors: M Sakoh; L Ostergaard; A Gjedde; L Røhl; P Vestergaard-Poulsen; D F Smith; D Le Bihan; S Sakaki; C Gyldensted Journal: J Neurosurg Date: 2001-09 Impact factor: 5.115
Authors: B K Menon; E E Smith; J Modi; S K Patel; R Bhatia; T W J Watson; M D Hill; A M Demchuk; M Goyal Journal: AJNR Am J Neuroradiol Date: 2011-07-28 Impact factor: 3.825
Authors: M Wintermark; R Meuli; P Browaeys; M Reichhart; J Bogousslavsky; P Schnyder; P Michel Journal: Neurology Date: 2007-02-27 Impact factor: 9.910
Authors: Matthew B Maas; Michael H Lev; Hakan Ay; Aneesh B Singhal; David M Greer; Wade S Smith; Gordon J Harris; Elkan Halpern; André Kemmling; Walter J Koroshetz; Karen L Furie Journal: Stroke Date: 2009-07-09 Impact factor: 7.914
Authors: Jeremy J Heit; Michael Mlynash; Stephanie M Kemp; Maarten G Lansberg; Soren Christensen; Michael P Marks; Santiago Ortega-Gutierrez; Gregory W Albers Journal: Stroke Date: 2019-05 Impact factor: 7.914
Authors: Mina Park; Kyung-Eun Kim; Na-Young Shin; Seung-Koo Lee; Soo Mee Lim; Dongbeom Song; Ji Hoe Heo; Jin Woo Kim; Se Won Oh Journal: Eur Radiol Date: 2015-09-22 Impact factor: 5.315
Authors: Adam de Havenon; Michael Mlynash; May A Kim-Tenser; Maarten G Lansberg; Thalabe Leslie-Mazwi; Soren Christensen; Ryan A McTaggart; Matthew Alexander; Gregory Albers; Joseph Broderick; Michael P Marks; Jeremy J Heit Journal: Stroke Date: 2019-03 Impact factor: 7.914
Authors: Leonard L L Yeo; Prakash Paliwal; Adrian F Low; Edgar L W Tay; Anil Gopinathan; Mahendran Nadarajah; Eric Ting; Narayanaswamy Venketasubramanian; Raymond C S Seet; Aftab Ahmad; Bernard P L Chan; Hock L Teoh; Derek Soon; Rahul Rathakrishnan; Vijay K Sharma Journal: Neurology Date: 2016-01-06 Impact factor: 9.910
Authors: Seyedmehdi Payabvash; Nils H Petersen; Khalid Al-Dasuqi; Gerardo A Torres-Flores; Sumita M Strander; Cindy Khanh Nguyen; Krithika U Peshwe; Sreeja Kodali; Andrew Silverman; Ajay Malhotra; Michele H Johnson; Charles C Matouk; Joseph L Schindler; Lauren H Sansing; Guido J Falcone; Kevin N Sheth Journal: Stroke Date: 2020-08-12 Impact factor: 7.914
Authors: Tobias Djamsched Faizy; Reza Kabiri; Soren Christensen; Michael Mlynash; Gabriella Kuraitis; Marius Marc-Daniel Mader; Gregory W Albers; Maarten G Lansberg; Jens Fiehler; Max Wintermark; Michael P Marks; Jeremy J Heit Journal: Neurology Date: 2021-05-05 Impact factor: 9.910
Authors: Tobias D Faizy; Reza Kabiri; Soren Christensen; Michael Mlynash; Gabriella Kuraitis; Gabriel Broocks; Uta Hanning; Jawed Nawabi; Maarten G Lansberg; Michael P Marks; Gregory W Albers; Jens Fiehler; Max Wintermark; Jeremy J Heit Journal: J Cereb Blood Flow Metab Date: 2021-02-08 Impact factor: 6.200